Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression

Only 30% of patients with major depressive disorder (MDD) reach full recovery or remission. Treatment-resistant depression (TRD) is MDD that does not respond to adequate treatment attempts with at least two antidepressants. TRD is associated more with immune activation than with treatment responsive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauden, Ari, Geishin, Akim, Merzon, Eugene, Korobeinikov, Andrew, Green, Ilan, Golan-Cohen, Avivit, Vinker, Shlomo, Manor, Iris, Weizman, Abraham, Magen, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474658/
https://www.ncbi.nlm.nih.gov/pubmed/34589804
http://dx.doi.org/10.1016/j.bbih.2021.100313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474658/
https://www.ncbi.nlm.nih.gov/pubmed/34589804
http://dx.doi.org/10.1016/j.bbih.2021.100313

Ejemplares similares